Overview of bovine spongiform encephalopathy and related events in Germany
by Roxanne E. Lewis, Daniel Krewski, Michael G. Tyshenko
International Journal of Risk Assessment and Management (IJRAM), Vol. 14, No. 1/2, 2010

Abstract: Despite the emergence of bovine spongiform encephalopathy (BSE) throughout Europe, Germany considered itself free of the disease. However, on November 26, 2000, the first domestic case of BSE appeared in the country, leading to public concerns about food safety. The occurrence of BSE within the country's borders had dramatic economic and social effects. The response of the German public and politicians far surpassed that in the UK, which was affected by the disease to a much greater extent. Germany's response to BSE was rapid, with new risk management policies, including testing a high percentage of cattle, implemented within months. To date, Germany has not had a case of variant Creutzfeldt-Jakob disease (vCJD). The strong public reaction to the identification of BSE in Germany demonstrates the importance of taking public perceptions of and concerns about zoonotic diseases into account in risk management decision-making.

Online publication date: Fri, 17-Sep-2010

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Risk Assessment and Management (IJRAM):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com